Literature DB >> 12120826

Apparent failure of endocarditis prophylaxis caused by penicillin-resistant Streptococcus mitis.

Glen E Hall1, Larry M Baddour.   

Abstract

Antibiotic resistance among viridans streptococci has increased with Streptococcus mitis being more resistant than other viridans species. In a case presented in this report, it is possible that antibiotic resistance contributed to an apparent failure of endocarditis prophylaxis. The patient had undergone periodontal surgery on 2 separate occasions and in both instances was administered 2 g of amoxicillin orally 1 hour before each procedure. He subsequently developed a subacute illness and had multiple blood cultures drawn that grew S. mitis with a minimum inhibitory concentration of 1.0 microg/mL for penicillin. Transesophageal echocardiogram provided further evidence of infective endocarditis with vegetations seen on the anterior leaflet of the mitral valve. Combination therapy with high-dose intravenous aqueous crystalline penicillin G and gentamicin sulfate for 4 weeks was curative. Clindamycin, rather than amoxicillin, has since been used as dental prophylaxis for subsequent procedures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12120826     DOI: 10.1097/00000441-200207000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002.

Authors:  Rajesh M Prabhu; Kerryl E Piper; Larry M Baddour; James M Steckelberg; Walter R Wilson; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Dentistry and Endocarditis.

Authors:  Michael J Wahl; Thomas J Pallasch
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

3.  Whole genome sequencing as a tool for phylogenetic analysis of clinical strains of Mitis group streptococci.

Authors:  L H Rasmussen; R Dargis; K Højholt; J J Christensen; O Skovgaard; U S Justesen; F S Rosenvinge; C Moser; O Lukjancenko; S Rasmussen; X C Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-20       Impact factor: 3.267

4.  Characterization of the fibrinogen binding domain of bacteriophage lysin from Streptococcus mitis.

Authors:  Ho Seong Seo; Paul M Sullam
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

5.  Structure of the lectin regulatory domain of the cholesterol-dependent cytolysin lectinolysin reveals the basis for its lewis antigen specificity.

Authors:  Susanne C Feil; Sara Lawrence; Terrence D Mulhern; Jessica K Holien; Eileen M Hotze; Stephen Farrand; Rodney K Tweten; Michael W Parker
Journal:  Structure       Date:  2012-02-08       Impact factor: 5.006

6.  Bacteriophage lysin mediates the binding of streptococcus mitis to human platelets through interaction with fibrinogen.

Authors:  Ho Seong Seo; Yan Q Xiong; Jennifer Mitchell; Ravin Seepersaud; Arnold S Bayer; Paul M Sullam
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Characterization of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin domain.

Authors:  Stephen Farrand; Eileen Hotze; Paul Friese; Susan K Hollingshead; David F Smith; Richard D Cummings; George L Dale; Rodney K Tweten
Journal:  Biochemistry       Date:  2008-06-14       Impact factor: 3.162

Review 8.  Advances in structure determination by cryo-EM to unravel membrane-spanning pore formation.

Authors:  Harry Scott; Wei Huang; James G Bann; Derek J Taylor
Journal:  Protein Sci       Date:  2018-09       Impact factor: 6.725

9.  Manipulating the Lewis antigen specificity of the cholesterol-dependent cytolysin lectinolysin.

Authors:  Sara L Lawrence; Susanne C Feil; Jessica K Holien; Michael J Kuiper; Larissa Doughty; Olan Dolezal; Terrence D Mulhern; Rodney K Tweten; Michael W Parker
Journal:  Front Immunol       Date:  2012-11-05       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.